Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis

American Journal of Pathology

Volumn 152, Issue 1, 1998, Pages 63-74

  Sheu, Lai Fa ^a   Chen, Ann ^a   Wei, Yu Hui ^a   Ho, Kuo Chieh ^b   Cheng, Jye Young ^a   Meng, Ching Liang ^a   Lee, Wei Hwa ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; EPSTEIN BARR VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL DEATH; COLONY FORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOEPITHELIOMA; MALIGNANT TRANSFORMATION; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA;

ADENOCARCINOMA; ANIMALS; ANTISENSE ELEMENTS (GENETICS); APOPTOSIS; CARCINOGENICITY TESTS; CARCINOMA; CELL DIVISION; COLONY-FORMING UNITS ASSAY; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, INBRED BALB C; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR STEM CELLS; VIRAL MATRIX PROTEINS;

EID: 0031964285     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Miller G: Epstein-Barr virus: biology, pathogenesis, and medical aspects. Virology. Edited by Fields BN, Knipe DM. New York, Raven Press, 1990, pp 1921-1958
2. Harabuchi Y, Imai S, Wakashima J, Hirao M, Kataura A, Osato T, Kon S: Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 1996, 77: 2137-2149
3. Chiang AKS, Tao Q, Srivastava G, Ho FCS: Nasal NK-and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 1996, 68: 285-290
4. Herbst H, Niedobitek G, Kneba M, Hummel M, Finn T, Anagnostopoulos I, Bergholz M, Krieger G, Stein H: High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol 1990, 137: 13-18
5. Burke AP, Yen TS, Shekitka KM, Sobin LH: Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990, 3: 377-380
6. Shibata D, Weiss LM: Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992, 140: 769-774
7. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T: Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994, 91: 9131-9135
8. Levine PH, Stemmermann G, Lennette ET, Hildesheim A, Shibata D, Nomura A: Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr virus-associated gastric adenocarcinoma. Int J Cancer 1995, 60: 642-644
9. Harn HJ, Chang JY, Wang MW, Ho LI, Lee HS, Chiang JH, Lee WH: Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Hum Pathol 1995, 26: 267-271
10. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T: Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br J Cancer 1996, 74: 625-631
11. Kida Y, Miyauchi K, Takano Y: Gastric adenocarcinoma with differentiation to sarcomatous components associated with monoclonal Epstein-Barr virus infection and LMP1 expression. Virchows Arch A Pathol Anat 1993, 423: 383-387
12. Fennewald S, van Santen V, Kieff E: The nucleotide sequence of a messenger RNA transcribed in latent growth transforming virus infection indicates that it may encode a membrane protein. J Virol 1984, 51: 411-419
13. Hennessy K, Fennewald S, Hummel M, Cole T, Kieff E: A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc Natl Acad Sci USA 1984. 81: 7201-7211
14. Liebowitz D, Wang D, Kieff E: Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J Virol 1986, 58: 233-237
15. Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kD tumor necrosis receptor. Cell 1994, 78: 681-692
16. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signalling protein for the tumor necrosis factor receptor family. Cell 1995, 80: 389-399
17. Wang D, Leibowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocyte transforms established rodent cells. Cell 1985, 43: 831-840
18. Baichwal VJ, Sugden B: Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 1988, 2: 461-467
19. Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E: Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol 1988, 62: 4173-4184
20. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991, 65: 1107-1114
21. Hammarskjold ML, Simurda MC: Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J Virol 1992, 66: 6496-6501
22. κB. J Biol Chem 1992, 267: 24157-24160
23. Okan I, Wang Y, Chen F, Hu LF, Imreh S, Klein G, Wiman KG: The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 1995, 11: 1027-1031
24. Kaye KM, Izumi KM, Kieff E: Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation: Proc Natl Acad Sci USA 1993, 90: 9150-9154
25. Dawson CW, Rickinson AB, Young LS: Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990, 344: 777-780
26. Fahraeus R, Rymo L, Rhim JS, Klein G: Morphological transformation of human keratinocyte expressing the LMP gene of Epstein-Barr virus. Nature 1990, 345: 447-449
27. Miller WE, Shelton Earp H, Raab-Traub N: The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 1995, 69: 4390-4398
28. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ: Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 1990, 61: 1315-1327
29. Hammerschmidt W, Sugden B, Baichwal VR: The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high level. J Virol 1989, 63: 2469-2475
30. Lu JJY, Chen JY, Hsu TY, Yu WCY, Su IJ, Yang CS: Induction of apoptosis in epithelial cell by Epstein-Barr virus latent membrane protein 1. J Gen Virol 1996, 77: 1883-1892
31. Oda K, Tamaru J, Takenouchi T, Mikata A, Nunomura M, Saitoh N, Sarashina H, Nakajima N: Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol 1993, 143: 1063-1071
32. Glaser R, Zhang HY, Yao K, Zhu HC, Wang FX, Li GY, Wen DS, Li YP: Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 1989, 86: 9524-9528
33. Hu LF, Zabarowsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991, 72: 2399-2409
34. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992, 7: 2131-2140
35. Mann KP, Staunton D, Thorley-Lawson DA: Epstein-Barr virus encoded protein found in plasma membrane of transformed cells. J Virol 1985, 55: 710-720
36. Sheu LF, Chen A, Meng CL, Ho KC, Lin FG. Lee WH: Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: association with p53 expression. Hum Pathol 1997, 28: 556-562
37. Haldar S, Negrini M, Monne M, Sabvioni S, Croce CM: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 1994, 54: 2095-2097
38. Wagner AJ, Small MB, Hay N. Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 1993, 13: 2432-2440
39. Martin JM, Veis D, Korsmeyer SJ, Sugden B: Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J Virol 1993, 67: 5269-5278
40. Knecht H, Brousset P, Bachmann E. Sandvej K. Odermatt BF: Latent membrane protein 1 a key oncogene in EBV-related carcinogenesis? Acta Haematol 1993, 90: 167-171
41. Ziegler SF, Whitlock CA, Goff SP, Gifford A, Witte ON: Lethal effect of the Abelson murine leukemia virus transforming product. Cell 1981, 27: 477-486
42. Tarpley WG, Temin HM: The location of v-src in a retrovirus determines whether the virus is toxic or transforming. Mol Cell Biol 1984, 4: 2653-2660
43. Schwartz RC, Witte ON: A recombinant murine retrovirus expressing v-rel is cytopathic. Virology 1988, 165: 182-190
44. Evan GL, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblast by c-Myc protein. Cell 1992, 69: 119-128
45. Tsujimoto Y, Cossman J, Jaffe E, Croce M: Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985, 228: 1441-1443
46. Wagner AJ, Small MB, Hay N: Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 1993, 13: 2432-2440
47. Cooper GM: Role of oncogenes and tumor suppressor genes in the pathogenesis of neoplasms. Oncogenes. Edited by Cooper GM. Boston, Jones and Bartlett Publishers, 1995, pp 162-180
48. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancer. Science 1991, 253: 49-53
49. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends Genet 1993, 9: 138-141
50. Kieff E, Liebowitz D: Epstein-Barr virus and its replication. Virology. Edited by Fields BN, Knipe DM. New York, Raven Press, 1990, pp 1889-1920
51. Tsujimoto Y: Overexpression of the human bcl-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc Natl Acad Sci USA 1989, 86: 1958-1962
52. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E: Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 1990, 64: 2309-2318
53. Kelleher CA, Kaufman Paterson RL, Dreyfus DH, Streib JE, Xu JW, Takase K, Jones JF, Gelfand EW: Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 1995, 208: 685-695
54. Kaufman Paterson RL, Kelleher CA, Streib JE, Amankonah TD, Xu JW, Jones JF, Gelfand EW: Activation of human thymocyte after infection by EBV. J Immunol 1995, 154: 1440-1449
55. Springer TA: Adhesion receptors of the immune system. Nature 1990, 346: 425-434
56. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Scully TB, Kieff E, Moss DJ: Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 1992, 176: 169-176
57. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B: Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988, 42: 329-338
58. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS: Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991, 1: 320-322
59. Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken JHJM, Pallesen G: Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 1993, 143: 1072-1085
60. Carbone A, Gloghini A, Volpe R, Boiocchi M, Tirelli U, Italian T: High frequency of Epstein-Barr virus latent membrane protein-1 expression in acquired immunodeficiency syndrome-related Ki-1 (CD30)-positive anaplastic large-cell lymphomas. Am J Clin Pathol 1994, 101: 768-772
61. Delecluse HJ, Kremmer E, Rouault JP, Cour C, Bornkamm G, Berger F: The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol 1995, 146: 1113-1120
62. Chetty R, Biddolph S, Kaklamanis L, Cary N, Stewart S, Giatromanolaki A, Gatter K: bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders J Pathol 1996, 180: 254-258
63. Rowe DT, Rowe M, Evan GI, Wallace LE, Farrell PJ, Rickinson AB: Restricted expression of EBV latent genes and T-lymphocyte detected membrane antigen in Burkitt's lymphoma cells. EMBO J 1986, 5: 2599-2607
64. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 1987, 6: 2743-2751
65. Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wirght DH, Young LS: Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma Blood 1995, 86: 659-665
66. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993, 82: 2937-2942
67. Chen WG, Chen YY, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM: Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 1996, 148: 17-23
68. Sandvej K, Peh SC, Andresen BS, Pallesen G: Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994, 84: 4053-4060
69. Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF: Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 1995, 10: 523-528
70. Chang YS, Su IJ, Chung PJ, Shu CH, Ng CK, Wu SJ, Liu ST: Detection of an Epstein-Barr virus variant in T-cell lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995, 62: 673-677
71. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G: Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 1993, 8: 1575-1583
72. Trivedi P, Hu LF, Chen Fu, Christensson B, Masucci MG, Klein G, Winberg G: Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 1994, 30A: 84-88
73. Busson P, Zhang Q, Guillon JM, Gregory CD, Young LS, Clausse B, Lipinski M, Rickinson AB, Tursz T: Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells. Int J Cancer 1992, 50: 863-867
74. Lynn TC, Wang JH, Yang CS, Tu SM: Natural killer cell activity in patients with nasopharyngeal carcinoma. Chin J Microbiol Immunol 1986, 19: 177-182
75. Lakhdar M, Oueslati R, Ellouze R, Thameur H, Cammoun M, Khedhiri N, Kastally R: High interferon titer and defective NK-cell activity in the circulation of nasopharyngeal carcinoma patients. Int J Cancer 1989, 43: 543-548
76. Lu QL, Elia G, Lucas S, Thomas A: Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer 1993, 53: 29-35
77. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Muller-Lantzsch N, Stein H: Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991, 88: 4766-4770
78. Jiwa NM, Oudejans JJ, Bai MC, van der Brule AJC, Horstman A, Vos W, van der Valk P, Kluin PHM, Walboomers JMM, Meijer CJLM: Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms. Histopathology 1995, 26: 547-553
79. Schlaifer D, Brousset P, Attal M, Massip P, Payen C, Marchou B, Huguet F, Muller C, Laurent G, Pris J, Delsol G: bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopathology 1994, 25: 77-82
80. Camilleri-Broet S, Davi F, Feuillard J, Bourgeois C, Seilhean D, Hauw JJ, Raphael M: High expression of latent membrane protein 1 of Epstein-Barr virus and bcl-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood 1995, 86: 432-435
81. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990, 348: 334-348
82. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A: Epstein-Barr virus-coded BHRF-1 protein, a viral homologue of bcl-2, protects human B-cells from programmed cell death. Proc Natl Acad Sci USA 1993, 90: 8479-8483
83. Oudejans JJ, van den Brule AJC, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, Walboomers JMM, Meijer CJLM: BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 proto-oncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocyte. Blood 1995, 86: 1893-1902
84. Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G: The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. J Gen Virol 1989, 70: 2989-3002
85. Gregory CD, Murray RJ, Edwards CF, Rickinson AB: Down-regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 1988, 167: 1811-1824
86. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG: Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol 1996, 27: 20-27